First-Dose Idarubicin Cardiomyopathy: A Case Of New Heart Failure After Induction Chemotherapy For Acute Myeloid Leukaemia

Anthracyclines are an effective chemotherapy agent. However, very few cases of idarubicin-induced cardiomyopathy exist. Herein, we describe a case of first-dose idarubicin-related acute heart failure in a woman with a history of myelodysplastic syndrome converted to acute myeloid leukaemia.